Learning Early Infant Feeding Cues
Launched by FLORIDA STATE UNIVERSITY · Nov 8, 2023
Trial Information
Current as of November 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Learning Early Infant Feeding Cues," aims to understand how mothers can better recognize when their babies are hungry or full—this is known as responsive feeding. The study will focus on mothers who are enrolled in government-supported home visiting programs and will explore what helps or hinders them in using these feeding techniques. Researchers want to improve a program that teaches these skills and find out if the updated approach is helpful and acceptable to mothers.
To participate, mothers need to be in their third trimester of pregnancy, at least 18 years old, and able to speak English or Spanish. They should be expecting to keep custody of their baby after birth and have a healthy pregnancy. If eligible, mothers will join focus groups to share their feeding experiences, receive personalized coaching during feeding times at home, and complete online surveys. The study will start when mothers are close to giving birth and continue until their babies are six months old, with the goal of helping families foster healthy feeding habits.
Gender
FEMALE
Eligibility criteria
- • Maternal Inclusion Criteria
- • Pregnant mother in the 3rd trimester (28 weeks or beyond)
- • Enrolled in a government-funded maternal-child home visiting program
- • Maternal age 18 years or older
- • English or Spanish speaking
- • Anticipated to have custody of infant after birth
- • Healthy pregnancy, no complications that are anticipated to result in a preterm birth or extended hospital stay for mother or infant
- • Maternal Exclusion Criteria
- • Gave birth to multiple fetuses
- • Age less than 18 years
- • Not fluent in English or Spanish
- • Expected to not have custody of the infant after birth
- • Infant inclusion criteria
- • Born as a singleton (not a twin, triplet, etc.) to a mother enrolled in a maternal-child home visiting program
- • Born full term (37 weeks or beyond)
- • Infant exclusion criteria
- • Congenital anomaly that may interfere with infant feeding or growth after birth (i.e., Down Syndrome, cleft lip/palate)
- • Born preterm (born prior to 37 weeks)
- • NICU stay beyond 48 hours
- • Infant diagnosis of failure to thrive
- • Supplemental oxygen
- • Enteral feeding device used for feedings
About Florida State University
Florida State University (FSU) is a prestigious public research institution located in Tallahassee, Florida, known for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, FSU leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the medical community. The university fosters a collaborative environment that brings together multidisciplinary teams to design, implement, and analyze clinical studies, ensuring adherence to the highest ethical and scientific standards. Through its clinical trials, FSU aims to address critical health challenges and translate research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported